Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories
Titel:
Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories
Auteur:
Fiegl, M. Erdel, M. Tinhofer, I. Brychtova, Y. Panovska, A. Doubek, M. Eigenberger, K. Fonatsch, C. Hopfinger, G. Mühlberger, H. Zabernigg, A. Falkner, F. Gastl, G. Mayer, J. Greil, R.